1. Etiology and management of pyoderma gangrenosum: a comprehensive review;Ahronowitz;Am J Clin Dermatol,2012
2. Pyoderma gangrenosum: an updated review;Ruocco;J Eur Acad Dermatol Venereol,2009
3. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial;Brooklyn;Gut,2006
4. Healthcare Cost and Utilization Project (HCUP). Overview of the Nationwide Inpatient Sample (NIS) [Agency for Healthcare Research and Quality], 2003-2012. Available at: www.hcup-usahrq.gov/nisoverview.jsp. Accessed February 1, 2015.
5. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study;Langan;J Invest Dermatol,2012